The Psychedelic Therapy and Integration Conference aims to scientifically and comprehensively integrate knowledge and research on the use of psychoactive substances in treating conditions such as treatment-resistant depression, post-traumatic stress disorder (PTSD), and addiction. The therapeutic application of psychoactive substances is gaining a growing following among scientists and therapists worldwide. It is already legal in the USA (Oregon), Australia, and Israel and the process of decriminalization has already started in the Netherlands. The therapeutic potential of such treatments is also being considered by the European Parliament.

HoloMind seeks to inform attendees about the latest methods for treating depression and PTSD, while also promoting harm reduction associated with the illegal use of psychoactive substances as part of our educational mission.

Learn more and register here.